Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Notable Labs (NTBL) Stock Forecast & Price Target

Notable Labs logo
Get the Latest News and Ratings for NTBL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Notable Labs and its competitors.

Sign Up

NTBL Analyst Ratings Over Time

TypeCurrent Forecast
11/28/23 to 11/27/24
1 Month Ago
10/29/23 to 10/28/24
3 Months Ago
8/30/23 to 8/29/24
1 Year Ago
11/28/22 to 11/28/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$7.00$7.00$7.00$13.00
Forecasted Upside2,723.72% Upside2,723.72% Upside1,038.40% Upside229.95% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Buy
Buy

NTBL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

NTBL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Notable Labs Stock vs. The Competition

TypeNotable LabsMedical CompaniesS&P 500
Consensus Rating Score
2.50
2.80
2.50
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside2,723.72% Upside25,264.12% Upside6.71% Upside
News Sentiment Rating
Neutral News

See Recent NTBL News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
9/20/2024JMP Securities
2 of 5 stars
S. Tuerkcan
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform
5/16/2024Chardan Capital
1 of 5 stars
K. Nakae
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$7.00 ➝ $5.00+376.19%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 09:35 AM ET.


NTBL Forecast - Frequently Asked Questions

According to the research reports of 2 Wall Street equities research analysts, the average twelve-month stock price forecast for Notable Labs is $7.00, with a high forecast of $9.00 and a low forecast of $5.00.

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Notable Labs in the last year. There is currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" NTBL shares.

According to analysts, Notable Labs's stock has a predicted upside of 2,723.72% based on their 12-month stock forecasts.

Over the previous 90 days, Notable Labs's stock had 1 downgrade by analysts.

Notable Labs has been rated by research analysts at JMP Securities in the past 90 days.

Analysts like Notable Labs less than other "medical" companies. The consensus rating score for Notable Labs is 2.50 while the average consensus rating score for "medical" companies is 2.80. Learn more on how NTBL compares to other companies.


This page (NASDAQ:NTBL) was last updated on 11/27/2024 by MarketBeat.com Staff
From Our Partners